CC
COLL icon

Corton Capital’s Collegium Pharmaceutical COLL Stock Holding History

Corton Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,555
Closed -$243K – 520
2024
Q2 		$243K Buy
7,555
+656
+10% +$22.7K 0.13% 270
2024
Q1 		$268K Sell
6,899
-744
-10% -$26K 0.1% 309
2023
Q4 		$235K Buy
+7,643
New +$191K 0.07% 411

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Corton Capital's COLL Position: Q3 2024 in Review

Corton Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2024, closing a stake of 7,555 shares — an estimated $243K sold.

Corton Capital first reported a position in COLL in Q4 2023 and held it in 3 quarters. The position peaked at $268K in Q1 2024. 249 funds tracked by Wall St. Rank hold COLL as of Q3 2024.

  • Corton Capital reported no remaining Collegium Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Corton Capital sold 7,555 Collegium Pharmaceutical shares in Q3 2024, an estimated $243K.
  • Corton Capital first reported a position in Collegium Pharmaceutical in Q4 2023 and held it in 3 quarters.
  • Corton Capital's Collegium Pharmaceutical position peaked at $268K in Q1 2024.
  • 249 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2024.

Based on Corton Capital's 13F filing for Q3 2024, filed 14 Nov 2024.